Building resilience needs to be central to treating drug-resistant tuberculosis.
Lancet Glob Health
; 9(4): e381-e382, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33740401
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Tuberculosis, Multidrug-Resistant
Type of study:
Qualitative_research
Limits:
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
Lancet Glob Health
Year:
2021
Document type:
Article